Hypogonadism and Low Testosterone Levels as a Side Effect of Methadone and Buprenorphine

authors:

avatar Ayman Fareed 1 , *

Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, USA
International Journal of High Risk Behaviors and Addiction: Vol.1, issue 2; 84-85
published online: July 25, 2012
article type: Letter
received: May 20, 2012
revised: June 5, 2012
accepted: June 10, 2012
DOI: https://doi.org/10.5812/ijhrba.6539

how to cite: Fareed A. Hypogonadism and Low Testosterone Levels as a Side Effect of Methadone and Buprenorphine. Int J High Risk Behav Addict. 2012;1(2): 84-85. https://doi.org/10.5812/ijhrba.6539.

References

  • 1.

    Heidari Z, Mahmoudzadeh-Sagheb H, Kohan F. A Quantitative and Qualitative Study of Rat Testis Following Administration of Methadone and Buprenorphine. Int J High Risk Behav Addict. 2012;1(1):12-5. https://doi.org/10.5812/ijhrba.4119.

  • 2.

    Bliesener N, Albrecht S, Schwager A, Weckbecker K, Lichtermann D, Klingmuller D. Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence. J Clin Endocrinol Metab. 2005;90(1):203-6. https://doi.org/10.1210/jc.2004-0929.

  • 3.

    Hallinan R, Byrne A, Agho K, McMahon CG, Tynan P, Attia J. Hypogonadism in men receiving methadone and buprenorphine maintenance treatment. Int J Androl. 2009;32(2):131-9. https://doi.org/10.1111/j.1365-2605.2007.00824.x.

  • 4.

    Colameco S, Coren JS, Zimmerman DJ. Buprenorphine-induced Symptomatic Hypogonadism in Men: Case Reports and Discussion. J Addict Med. 2008;2(3):147-50. https://doi.org/10.1097/ADM.0b013e318172d612.

  • 5.

    Cowan A. Buprenorphine: the basic pharmacology revisited. J Addict Med. 2007;1(2):68-72. https://doi.org/10.1097/ADM.0b013e31806c9202.